Gonçalo Bernardes
Gonçalo Bernardes
Group Leader - Department Chemistry, University of Cambridge
Verified email at cam.ac.uk
Cited by
Cited by
Advances in chemical protein modification
O Boutureira, GJL Bernardes
Chemical reviews 115 (5), 2174-2195, 2015
Chemical modification of proteins at cysteine: opportunities in chemistry and biology
JM Chalker, GJL Bernardes, YA Lin, BG Davis
Chemistry–An Asian Journal 4 (5), 630-640, 2009
Allyl sulfides are privileged substrates in aqueous cross-metathesis: application to site-selective protein modification
YA Lin, JM Chalker, N Floyd, GJL Bernardes, BG Davis
Journal of the American Chemical Society 130 (30), 9642-9643, 2008
Developing drug molecules for therapy with carbon monoxide
CC Romão, WA Blättler, JD Seixas, GJL Bernardes
Chemical Society Reviews 41 (9), 3571-3583, 2012
Facile conversion of cysteine and alkyl cysteines to dehydroalanine on protein surfaces: versatile and switchable access to functionalized proteins
GJL Bernardes, JM Chalker, JC Errey, BG Davis
Journal of the American Chemical Society 130 (15), 5052-5053, 2008
Site-selective protein-modification chemistry for basic biology and drug development
N Krall, FP Da Cruz, O Boutureira, GJL Bernardes
Nature chemistry 8 (2), 103-113, 2016
Inverse electron demand Diels–Alder reactions in chemical biology
BL Oliveira, Z Guo, GJL Bernardes
Chemical Society Reviews 46 (16), 4895-4950, 2017
A “tag-and-modify” approach to site-selective protein modification
JM Chalker, GJL Bernardes, BG Davis
Accounts of chemical research 44 (9), 730-741, 2011
Methods for converting cysteine to dehydroalanine on peptides and proteins
JM Chalker, SB Gunnoo, O Boutureira, SC Gerstberger, ...
Chemical Science 2 (9), 1666-1676, 2011
A small‐molecule drug conjugate for the treatment of carbonic anhydrase IX expressing tumors
N Krall, F Pretto, W Decurtins, GJL Bernardes, CT Supuran, D Neri
Angewandte Chemie International Edition 53 (16), 4231-4235, 2014
Carbon‐monoxide‐releasing molecules for the delivery of therapeutic CO in vivo
S García‐Gallego, GJL Bernardes
Angewandte Chemie International Edition 53 (37), 9712-9721, 2014
CORM-3 Reactivity toward Proteins: The Crystal Structure of a Ru (II) Dicarbonyl− Lysozyme Complex
T Santos-Silva, A Mukhopadhyay, JD Seixas, GJL Bernardes, CC Romao, ...
Journal of the American Chemical Society 133 (5), 1192-1195, 2011
From disulfide‐to thioether‐linked glycoproteins
GJL Bernardes, EJ Grayson, S Thompson, JM Chalker, JC Errey, ...
Angewandte Chemie 120 (12), 2276-2279, 2008
Sulfur‐Limonene Polysulfide: A Material Synthesized Entirely from Industrial By‐Products and Its Use in Removing Toxic Metals from Water and Soil
MP Crockett, AM Evans, MJH Worthington, IS Albuquerque, AD Slattery, ...
Angewandte Chemie International Edition 55 (5), 1714-1718, 2016
Posttranslational mutagenesis: A chemical strategy for exploring protein side-chain diversity
TH Wright, BJ Bower, JM Chalker, GJL Bernardes, R Wiewiora, WL Ng, ...
Science 354 (6312), 2016
The direct formation of glycosyl thiols from reducing sugars allows one‐pot protein glycoconjugation
GJL Bernardes, DP Gamblin, BG Davis
Angewandte Chemie 118 (24), 4111-4115, 2006
A traceless vascular‐targeting antibody–drug conjugate for cancer therapy
GJL Bernardes, G Casi, S Trüssel, I Hartmann, K Schwager, ...
Angewandte Chemie International Edition 51 (4), 941-944, 2012
Synthetically defined glycoprotein vaccines: current status and future directions
R Adamo, A Nilo, B Castagner, O Boutureira, F Berti, GJL Bernardes
Chemical science 4 (8), 2995-3008, 2013
Curative properties of noninternalizing antibody–drug conjugates based on maytansinoids
E Perrino, M Steiner, N Krall, GJL Bernardes, F Pretto, G Casi, D Neri
Cancer research 74 (9), 2569-2578, 2014
De novo design of potent and selective mimics of IL-2 and IL-15
DA Silva, S Yu, UY Ulge, JB Spangler, KM Jude, C Labão-Almeida, LR Ali, ...
Nature 565 (7738), 186-191, 2019
The system can't perform the operation now. Try again later.
Articles 1–20